Open AccessPhase III Gynecologic Oncology Group Study of Advanced Ovarian Cancer: Bevacizumab Added to Initial Chemotherapy Extends Progression-Free Survival
Publication year - 2010
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000387947.51553.29
Subject(s) - bevacizumab , gynecologic oncology , oncology , medicine , chemotherapy , ovarian cancer , epithelial ovarian cancer , progression free survival , gynecologic cancer , cancer , gynecology